Recurrent myocardial infarction and emergency department visits: a retrospective study on the Stockholm Area Chest Pain Cohort

Background Patients who experience acute myocardial infarction (AMI) are at risk of recurrent AMI. Contemporary data on recurrent AMI and its association with return emergency department (ED) visits for chest pain are needed. Methods This Swedish retrospective cohort study linked patient-level data from six participating hospitals to four national registers to construct the Stockholm Area Chest Pain Cohort (SACPC). The AMI cohort included SACPC participants visiting the ED for chest pain diagnosed with AMI and discharged alive (first primary diagnosis of AMI during the study period not necessarily the patient’s first AMI). The rate and timing of recurrent AMI events, return ED visits for chest pain and all-cause mortality were determined during the year following index AMI discharge. Results Among 1 37 706 patients presenting to the ED with chest pain as principal complaint from 2011 to 2016, 5.5% (7579/137 706) were hospitalised with AMI. In total, 98.5% (7467/7579) of patients were discharged alive. In the year following index AMI discharge, 5.8% (432/7467) of AMI patients experienced ≥1 recurrent AMI event. Return ED visits for chest pain occurred in 27.0% (2017/7467) of index AMI survivors. During a return ED visit, recurrent AMI was diagnosed in 13.6% (274/2017) of patients. One-year all-cause mortality was 3.1% in the AMI cohort and 11.6% in the recurrent AMI cohort. Conclusions In this AMI population, 3 in 10 AMI survivors returned to the ED for chest pain in the year following AMI discharge. Furthermore, over 10% of patients with return ED visits were diagnosed with recurrent AMI during that visit. This study confirms the high residual ischaemic risk and associated mortality among AMI survivors.

[1]  Kai Kang,et al.  National Hospital Ambulatory Medical Care Survey: 2020 Emergency Department Summary Tables , 2022 .

[2]  A. di Lenarda,et al.  Incidence, Characteristics, and Management of Patients with Recurrent Myocardial Infarctions: Insights from the EYESHOT POST-MI , 2022, Journal of interventional cardiology.

[3]  S. Kapadia,et al.  Characteristics and Outcomes of Early Recurrent Myocardial Infarction After Acute Myocardial Infarction , 2021, Journal of the American Heart Association.

[4]  T. Djärv,et al.  Emergency department crowding associated with increased 30‐day mortality: a cohort study in Stockholm Region, Sweden, 2012 to 2016 , 2020, Journal of the American College of Emergency Physicians open.

[5]  M. Woodward,et al.  Trends in Recurrent Coronary Heart Disease Following Myocardial Infarction Among US Women and Men Between 2008 and 2017. , 2020, Circulation.

[6]  S. Normand,et al.  Association Between Subsequent Hospitalizations and Recurrent Acute Myocardial Infarction Within 1 Year After Acute Myocardial Infarction , 2020, Journal of the American Heart Association.

[7]  T. N. Harrison,et al.  Sex-Specific Trends in Acute Myocardial Infarction Within an Integrated Healthcare Network, 2000 Through 2014 , 2020, Circulation.

[8]  E. Peterson,et al.  Readmissions After Acute Myocardial Infarction: How Often Do Patients Return to the Discharging Hospital? , 2019, Journal of the American Heart Association.

[9]  Ting Zhao,et al.  The prevalence of 30‐day readmission after acute myocardial infarction: A systematic review and meta‐analysis , 2019, Clinical cardiology.

[10]  S. Normand,et al.  Twenty-Year Trends in Outcomes for Older Adults With Acute Myocardial Infarction in the United States , 2019, JAMA network open.

[11]  A. Wikman,et al.  Survival and resource utilization in patients with chest pain evaluated with cardiac troponin T compared with high-sensitivity cardiac troponin T. , 2017, International journal of cardiology.

[12]  J. Ludvigsson,et al.  The Swedish cause of death register , 2017, European Journal of Epidemiology.

[13]  Magnus Lundbäck,et al.  Trends in admissions for chest pain after the introduction of high-sensitivity cardiac troponin T. , 2017, International journal of cardiology.

[14]  P. Erne,et al.  Treatment and outcomes of patients with recurrent myocardial infarction: A prospective observational cohort study. , 2016, Journal of cardiology.

[15]  J. Greenslade,et al.  Assessment of the European Society of Cardiology 0-Hour/1-Hour Algorithm to Rule-Out and Rule-In Acute Myocardial Infarction , 2016, Circulation.

[16]  B. Wettermark,et al.  The First Decade with the Swedish Prescribed Drug Register – A Systematic Review of the Output in the Scientific Literature , 2016, Basic & clinical pharmacology & toxicology.

[17]  T. Jernberg,et al.  Cardiovascular risk in post-myocardial infarction patients: nationwide real world data demonstrate the importance of a long-term perspective. , 2015, European heart journal.

[18]  C. Rapezzi,et al.  Long-term outcomes and causes of death after acute coronary syndrome in patients in the Bologna, Italy, area. , 2015, The American journal of cardiology.

[19]  C. Held,et al.  SWEDEHEART Annual Report 2012 , 2014 .

[20]  Leora I. Horwitz,et al.  Diagnoses and timing of 30-day readmissions after hospitalization for heart failure, acute myocardial infarction, or pneumonia. , 2013, JAMA.

[21]  S. Blankenberg,et al.  Serial changes in highly sensitive troponin I assay and early diagnosis of myocardial infarction. , 2011, JAMA.

[22]  J. Ludvigsson,et al.  External review and validation of the Swedish national inpatient register , 2011, BMC public health.

[23]  L. Wallentin,et al.  Abstract 1428: Statin Use After Myocardial Iinfarction Improves Survival in Nearly All With Renal Dysfunction: Data From the Swedish Web-system for Enhancement and Development of Evidence-based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART) , 2009 .

[24]  J. Ludvigsson,et al.  The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research , 2009, European Journal of Epidemiology.

[25]  K. Murugiah,et al.  Incidence, predictors, and prognostic impact of recurrent acute myocardial infarction in China , 2020, Heart.

[26]  S. Mehta,et al.  Rule-In and Rule-Out of Myocardial Infarction Using Cardiac Troponin and Glycemic Biomarkers in Patients with Symptoms Suggestive of Acute Coronary Syndrome. , 2017, Clinical chemistry.

[27]  S. Raposeiras-Roubín,et al.  The Risk of Cardiovascular Events After an Acute Coronary Event Remains High, Especially During the First Year, Despite Revascularization. , 2016, Revista espanola de cardiologia.

[28]  J. Mehilli,et al.  [2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)]. , 2016, Giornale italiano di cardiologia.

[29]  K. Mahaffey,et al.  ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation , 2012 .

[30]  S. Schappert National Hospital Ambulatory Medical Care Survey: 1992 Emergency Department Summary. , 1997, Vital and health statistics. Series 13, Data from the National Health Survey.